C-Rad AB (publ) risk profile

27 Normal where most of the sector sits

Measured 21 October 2026 from CRAD-B's filed statements. Recomputed nightly.

27 (Normal), driven by Market expectation at 55, over 4 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation55ElevatedStableOne-year price volatility — 39.4%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversion42ElevatedWorseningCash conversion — 0.53x
Leverage and coverageReads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company.
Competitive position5ContainedStableRevenue-growth gap against peers — +60.2 percentage points
Concentration46ElevatedStableGeographic concentration — 3,824 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for C-Rad AB (publ)